Aflibercept high-dose (8mg) related intraocular inflammation (IOI) – a case series
Laura Hoffmann, Stephan Michels, Chiara Eandi, Muntadher Al Karam, Eva C. de Oliveira Figueiredo, Katja Hatz · 2024
Read Aflibercept high-dose (8mg) related intraocular inflammation (IOI) – a case series by Laura Hoffmann, Stephan Michels, Chiara Eandi, Muntadher Al Karam, Eva C. de Oliveira Figueiredo, Katja Hatz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11613492.txt.
Description
Laura Hoffmann and co-authors report eight cases in 2024 of eye swelling after a high-dose eye injection. The drug, given into the eye to treat vessel growth diseases, had looked as safe as its lower-dose form in large trials. Reports from real clinics still matter, so the team gathered cases from three centers.
All eight patients developed swelling inside the eye within two to seventeen days of the injection. All had received similar injections before without trouble, and none showed signs of deeper eye infection or vessel damage. Creams and drops calmed the swelling within about three weeks, and vision recovered well. The cause is unknown, and the authors urge clinics to watch for such cases.
Catalog record
| CREATOR | Laura Hoffmann, Stephan Michels, Chiara Eandi, Muntadher Al Karam, Eva C. de Oliveira Figueiredo, Katja Hatz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |